Leo Wealth, LLC Fate Therapeutics Inc Transaction History
Leo Wealth, LLC
- $1.09 Trillion
- Q3 2024
A detailed history of Leo Wealth, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Leo Wealth, LLC holds 10,439 shares of FATE stock, worth $26,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,439
Previous 10,439
-0.0%
Holding current value
$26,619
Previous $34.2 Million
6.71%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FATE
# of Institutions
185Shares Held
123MCall Options Held
15KPut Options Held
14K-
Redmile Group, LLC San Francisco, CA13.2MShares$33.6 Million2.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$27 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$25.8 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA8.22MShares$21 Million1.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.57MShares$14.2 Million0.6% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $247M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...